Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2016 Jan 1.

Published in final edited form as: Microvasc Res. 2014 Oct 28;97:167–180. doi: 10.1016/j.mvr.2014.10.008

Fig 1 — BRE pretreatment of TNF-α/IL-1β activated cells significantly decreased the level of ICAM-1 and VCAM-1 gene expression in HEMEC without having any effect on resting cells (A & C). BRE did not block the ICAM-1 and VCAM-1 gene expression in activated HIMEC, and slightly increased the expression of these genes in HIMEC (B & D). ELISA assay in culture media further support the inhibitory effect of BRE in HEMEC, but not in HIMEC (E & F). Values are means ±SD of 3 independent experiments. An asterisk denotes a significant difference in mean intensity between control and treated cells.

Fig 1 — BRE pretreatment of TNF-α/IL-1β activated cells significantly decreased the level of ICAM-1 and VCAM-1 gene expression in HEMEC without having any effect on resting cells (A & C). BRE did not block the ICAM-1 and VCAM-1 gene expression in activated HIMEC, and slightly increased the expression of these genes in HIMEC (B & D). ELISA assay in culture media further support the inhibitory effect of BRE in HEMEC, but not in HIMEC (E & F). Values are means ±SD of 3 independent experiments. An asterisk denotes a significant difference in mean intensity between control and treated cells.